Nelson B. Watts

Active 1987–2025

119
Papers
29,293
Citations
86
h-index
116
i10-index

Citations

Citations per year for Nelson B. Watts1986: 1 citations1991: 2 citations1992: 5 citations1993: 3 citations1994: 14 citations1995: 20 citations1996: 16 citations1997: 19 citations1998: 23 citations1999: 25 citations2000: 24 citations2001: 32 citations2002: 71 citations2003: 83 citations2004: 83 citations2005: 119 citations2006: 138 citations2007: 122 citations2008: 221 citations2009: 177 citations2010: 228 citations2011: 204 citations2012: 199 citations2013: 189 citations2014: 184 citations2015: 185 citations2016: 213 citations2017: 224 citations2018: 196 citations2019: 688 citations2020: 850 citations2021: 657 citations2022: 595 citations2023: 404 citations2024: 714 citations2025: 314 citations2026: 3 citations1987–1990: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,217 citing papers, 24.1% of this breakdownUnited Kingdom: 825 citing papers, 9% of this breakdownChina: 628 citing papers, 6.8% of this breakdownItaly: 492 citing papers, 5.4% of this breakdownCanada: 486 citing papers, 5.3% of this breakdownAustralia: 399 citing papers, 4.3% of this breakdownGermany: 332 citing papers, 3.6% of this breakdownFrance: 281 citing papers, 3.1% of this breakdownBelgium: 275 citing papers, 3% of this breakdownSwitzerland: 259 citing papers, 2.8% of this breakdownSpain: 245 citing papers, 2.7% of this breakdownNetherlands: 224 citing papers, 2.4% of this breakdown
0%24.1%Other 27.5%

Fields

  • Medicine85.2%
  • Biochemistry, Genetics and Molecular Biology8%
  • Engineering2%
  • Health Professions0.7%
  • Nursing0.6%
  • Dentistry0.5%
  • Other3%

Topics

  • Bone health and osteoporosis research16.2%
  • Bone health and treatments10.4%
  • Bone Metabolism and Diseases5.9%
  • Bone and Joint Diseases5.1%
  • Hip and Femur Fractures4%
  • Parathyroid Disorders and Treatments2.8%
  • Other55.6%

Coauthors

All papers

Open in search
  1. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

    Authors: , , , , , , , , , , , , , - Endocrine Practice 2020 cited by 1,109

  2. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016-Executive Summary

    Authors: , , , , , , , , , , , , , - Endocrine Practice 2016 cited by 1,144

  3. Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Riad A. Sulimani, Deborah Saunders, Jacques P. Brown, Juliet Compston, on behalf of the International Task Force on Osteonecrosis of the Jaw - Journal of Bone and Mineral Research 2014 cited by 1,345

  4. Treatment of Endometriosis-Associated Pain with Elagolix, an Oral GnRH Antagonist

    Authors: , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2017 cited by 493

  5. The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group

    Authors: , , , , , , , , , , , , , , , - Osteoporosis International 2014 cited by 663

  6. The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Osteoporosis International 2007 cited by 1,223

  7. Effects of Canagliflozin on Fracture Risk in Patients With Type 2 Diabetes Mellitus

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 449

  8. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis—2020 Update

    Authors: , , , - Endocrine Practice 2021 cited by 163

  9. Obesity Is Not Protective against Fracture in Postmenopausal Women: GLOW

    Authors: , , , , , , , , , , , , , , , , , , , , - The American Journal of Medicine 2011 cited by 551

  10. American Association of Clinical Endocrinologists/American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis— 2020 Update Executive Summary

    Authors: , , , , , , , , , , , , , - Endocrine Practice 2020 cited by 202

  11. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

    Authors: , , , - Osteoporosis International 2008 cited by 1,392

  12. Bisphosphonate-Associated Osteonecrosis of the Jaw: Report of a Task Force of the American Society for Bone and Mineral Research

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2007 cited by 1,648

  13. Osteoporosis in Men: An Endocrine Society Clinical Practice Guideline

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2012 cited by 602

  14. Evaluation of Bone Mineral Density and Bone Biomarkers in Patients With Type 2 Diabetes Treated With Canagliflozin

    Authors: , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2015 cited by 266

  15. Invasive Oral Procedures and Events in Postmenopausal Women With Osteoporosis Treated With Denosumab for Up to 10 Years

    Authors: , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 99

  16. Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials

    Authors: , , , , , , , , , , , , , , - The Lancet 2022 cited by 72

  17. Long-Term Outcomes of Elagolix in Women With Endometriosis

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Obstetrics and Gynecology 2018 cited by 133

  18. Underdiagnosis of Vertebral Fractures Is a Worldwide Problem: The IMPACT Study

    Authors: , , , , , , - Journal of Bone and Mineral Research 2005 cited by 558

  19. Elagolix for Heavy Menstrual Bleeding in Women with Uterine Fibroids

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2020 cited by 200

  20. American Association of Clinical Endocrinologists and American College of Endocrinology Clinical Practice Guidelines for the Diagnosis and Treatment of Postmenopausal Osteoporosis — 2016

    Authors: , , , , , , , , , , , , , - Endocrine Practice 2016 cited by 478

  21. Exogenous Testosterone or Testosterone with Finasteride Increases Bone Mineral Density in Older Men with Low Serum Testosterone

    Authors: , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2004 cited by 477

  22. Relationship of Weight, Height, and Body Mass Index With Fracture Risk at Different Sites in Postmenopausal Women: The Global Longitudinal Study of Osteoporosis in Women (GLOW)

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Bone and Mineral Research 2013 cited by 267

  23. Fundamentals and pitfalls of bone densitometry using dual-energy X-ray absorptiometry (DXA)

    Authors: - Osteoporosis International 2004 cited by 266

  24. Safety and Efficacy of 5 Years of Treatment With Recombinant Human Parathyroid Hormone in Adults With Hypoparathyroidism

    Authors: , , , , , , , , , , , , , - The Journal of Clinical Endocrinology & Metabolism 2019 cited by 66